论文信息 - Phase II study of docetaxel (D) plus bevacizumab (B) in Her/2 negative metastatic breast carcinoma (MBC). - 字舞流文

Phase II study of docetaxel (D) plus bevacizumab (B) in Her/2 negative metastatic breast carcinoma (MBC).

F. Kabbinavar | D. Slamon | D. Reese | C. Gottlieb | E. Hu | A. Wax | D. Chan | H. Allen | G. Patel | J. Sosa